drugset
drugset / Trial / NCT05367271

The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis

NCT05367271 ↗

Phase 2/3 Completed 62 enrolled Western Institute for Veterans Research
RandomizedParallel-groupSingle-blindTreatment

Summary

This single-blinded, randomized-controlled trial compares the efficacy of ultrasound-guided onabotulinumtoxinA (BTX-A) injections to the flexor digitorum brevis with current standard of care corticosteroid injections to the plantar fascia for the treatment of refractory plantar fasciitis in patients that have failed six weeks of non-operative treatment.

Timeline

Start
2022-08-23
Primary completion
2024-09-13
Completion
2024-09-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 20 iu Other
Comparator Dexamethasone Small molecule 4 mg Other
Background Lidocaine Other / unclassified 20 mg Other

Indications

plantar fasciitis